International Journal of Molecular and Cellular Medicine (IJMCM) is an open-access peer-reviewed quarterly journal devoted to all cellular & molecular biology and medicine disciplines such as the genetic basis of disease, biomarker discovery in diagnosis and treatment, genomics and proteomics, bioinformatics, computer applications in human biology, stem cells and tissue engineering, medical biotechnology, nanomedicine, cellular processes related to growth, death, and survival, clinical biochemistry, molecular & cellular immunology, molecular and cellular aspects of infectious disease and cancer research. International Journal of Molecular and Cellular Medicine (IJMCM) is a quarterly scientific publication of Babol University of Medical Sciences. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering the research ethics and academic rules and regulations.
All papers are subject to a double-blind reviewing process. The submitted papers will be published after a thorough review and the editorial board's approval. The honorable professors and researchers are highly appreciated if they visit this website, register, submit and set up their papers based on the Instructions to Authors. Therefore, visiting in person or calling the journal office is not recommended, so all connections with authors and reviewers are made through the website.
E-mail: info ijmcmed.org
| Bibliographic Information |
| Title |
International Journal of Molecular and Cellular Medicine |
| Journal Abbreviated Title |
Int. J. Mol. Cell. Med. |
| Journal Title Acronym |
IJMCM |
| CODEN |
IJMCJO |
| ISSN |
Print ISSN: 2251-9637
Online ISSN: 2251-9645 |
Subject
Category |
Scopus Subject Area and Category:
- Biochemistry
- Biotechnology
- Cell Biology
- Genetics
- Molecular Biology
- Molecular Medicine
Web of Science Categories:
Medicine, Research & Experimental |
| Coverage
|
- Cell Biology
- Cell interaction
- Cell membranes
- Cytology
- Gene expression
- Genetic regulation
- Genomics
- Medicine
- Molecular Biology
- Nanomedicine
- Reproduction
- Reproduction--Molecular aspects
- Stem Cells |
| Language |
English |
| Start Year |
2012 - Vol. 1, No. 1 - |
| Frequency |
Quarterly |
| Editor-in-Chief |
Hadi Parsian, Ph.D |
| Place of Publication |
Iran, Babol |
| Publisher |
Babol University of Medical Sciences |
| Status |
Active |
| Refereed |
Yes, Double Blind Peer Review |
| OCLC No. |
7831842466, 964891596, 941393343 |
| LC No. |
QH573 |
| MeSH |
Genomics | Nanomedicine | Stem Cells |
| NLM No. |
W1 |
| NLM ID |
101598104 |
| DDC No. |
599/.016 |
| URL |
http://www.ijmcmed.org/index.php |
| Type of Access |
Open Access (OA) |
| Type of License |
CC-BY-NC: Creative Commons — Attribution 4.0 International. |
| The Policy of Screening for Plagiarism |
All manuscripts must be free from plagiarism contents. Manuscripts submitted to the International Journal of Molecular and Cellular Medicine (IJMCM) will be screened for plagiarism using Similarity Check / iThenticate plagiarism detection tools.
All authors are suggested to use plagiarism detection software to do the similarity checking before submitting their manuscript to the journal.
Editors check the plagiarism detection of manuscripts in the International Journal of Molecular and Cellular Medicine (IJMCM) by using Grammarly detection software (www.grammarly.com) and using iThenticate since January 2018. The journal will immediately reject papers leading to plagiarism or self-plagiarism.
Whenever it is determined that the manuscript has not complied with the plagiarism rules, the article is rejected (before accepting) and if it has been published (after accepting), it will be removed from the published list and placed in the withdrawn list (returned articles because of Failure to observe plagiarism law). |
| Type of Publication (Processing Charges and Publication Charges) |
Publication charge for authors whose papers are accepted to the journal is as follows:
| For Iranian Authors |
For Overseas Authors |
Article Type |
| 20,000,000 IRR |
600 USD |
Review and original articles |
| 16,000,000 IRR |
500 USD |
Short Communication and Case Series Articles |
| 10,000,000 IRR |
400 USD |
Case Report articles |
| 5,000,000 IRR |
200 USD |
Letter to Editor articles |
Full text access: Open Access |
| Revenue Sources |
Institutional support, Donations |
| Type of Material |
Serial (Periodical) |
| Description |
International Journal of Molecular and Cellular Medicine (IJMCM) is an international open-access peer-reviewed quarterly journal in English devoted to the field of cellular & molecular biology and medicine disciplines. It is a quarterly scientific publication of Babol University of Medical Sciences. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering the research ethics and academic rules and regulations. |
| Copyright owner / Copyright holder |
Authors retain copyright to their work without restrictions. The author has complete control over the work (e.g. retains the right to reuse, distribute, republish etc.). |
| Authorship |
The consent of all authors, as well as related authorities/institutions has been received prior to the submission of the manuscript. The order of the authors (as to be reflected on the published article) has been established. The adding or deleting of authors once the manuscript has been accepted for publication would have to be accompanied by a signed statement of consent of all authors. All authors have contributed significantly to the research. Authors are obligated to participate in the peer review process, providing retractions/ corrections/ amendments when necessary. All conflicts of interest/financial support have been declared. Any changes or corrections to a published work require the consent of all authors. |
| COPE |
International Journal of Molecular and Cellular Medicine (IJMCM) follows the policies and guidelines of the Committee on Publication Ethics (COPE) and abides by its Code of Conduct in dealing with potential cases of misconduct. |
| Open Access Statement |
International Journal of Molecular and Cellular Medicine (IJMCM) is a fully open-access journal, which means that all articles are available on the Web to all users immediately upon publication. Non-commercial and commercial use and distribution in any medium is permitted, provided the author and the journal are properly credited. Benefits of open access for authors, include:
- Authors retain copyright to their work.
- Free access for all users worldwide.
- Increased visibility and readership.
- No spatial constraints.
- Rapid publication.
Authors pay an Article Processing Charge (APC) for manuscripts accepted after peer-review from January 1, 2025. |
Digital Archiving Policy
|
International Journal of Molecular and Cellular Medicine (IJMCM) works with some organizations as Islamic World Science Citation Database (ISC), The Iran National Library and Archives, and own server of Babol University of Medical Sciences for maintaining our own digital archive. This makes it possible the permanent availability and preservation of scholarly research and to ensure accessibility by converting and upgrading digital file formats to comply with new technology standards. |
| Data Citation |
Data should be cited in the same way as article, book, and web citations and authors are required to include data citations as part of their reference list. Data citation is appropriate for data held within institutional, subject focused, or more general data repositories. It is not intended to take the place of community standards such as in-line citation of GenBank accession codes. When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and in addition provide a formal citation in the reference list. International Journal of Molecular and Cellular Medicine (IJMCM) follows the format proposed by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)”. |
| Data Sharing Policy |
International Journal of Molecular and Cellular Medicine (IJMCM) uses the Basic Data Sharing Policy. The journal is committed to a more open research landscape, facilitating faster and more effective research discovery by enabling reproducibility and verification of data, methodology and reporting standards. International Journal of Molecular and Cellular Medicine (IJMCM) encourages authors to cite and share their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods, materials. Authors are encouraged to share or make open the data supporting the results or analyses presented in their article where this does not violate the protection of human subjects or other valid privacy or security concerns.
International Journal of Molecular and Cellular Medicine (IJMCM) encourages authors to share the data and other artifacts supporting the results in the article by archiving it in an appropriate public repository. Authors should include a Data Accessibility Statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
International Journal of Molecular and Cellular Medicine (IJMCM) requires authors of Original Investigation, and Special Paper articles to (1) place the de-identified data associated with the manuscript in a repository; and (2) include a Data Availability Statement in the manuscript describing where and how the data can be accessed.
International Journal of Molecular and Cellular Medicine (IJMCM) defines data as the digital materials underlying the results described in the manuscript, including but not limited to spreadsheets, text files, interview recordings or transcripts, images, videos, output from statistical software, and computer code or scripts. Authors are expected to deposit at least the minimum amount of data needed to reproduce the results described in the manuscript.
Data can be placed in any repository that makes data publicly available and provides a unique persistent identifier, including institutional repositories, general repositories (e.g., Figshare, Open Science Framework, Zenodo, Dryad, Harvard Dataverse, OpenICPSR), or discipline-specific repositories.
The Data Availability Statement should be placed in the manuscript at the end of the main text before the references. This statement must include (1) an indication of the location of the data; (2) a unique identifier, such as a digital object identifier (DOI), accession number, or persistent uniform resource locator (URL); and (3) any instructions for accessing the data, if applicable.
At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers.
Where one or multiple data sets are associated with a manuscript, these are not formally peer-reviewed as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of data. Any errors in the data rest solely with the producers of the data set(s).
Please note: As you are submitting your manuscript to the International Journal of Molecular and Cellular Medicine (IJMCM) where submissions are double-blind peer-reviewed, the main text file should not include any information that might identify the authors (i.e., Author Name, Address, Conflict of Interest and fund related information). As a data availability statement could reveal your identity, we recommend that you remove this from the anonymized version of the manuscript.
Exceptions to this policy will be made in rare cases in which de-identified data cannot be shared due to their proprietary nature or participant privacy concerns. Exceptions to policy and restrictions on data availability are granted for reasons associated with the protection of human privacy, issues such as biosafety, and/or to respect terms of use for data obtained under license from third parties. Confidential data, e.g., human subject or patient data, should always be anonymized, or permission to share should be obtained in advance. If in doubt, authors should seek counsel from their institution’s ethics committee.
Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper. Below a few examples:
Data Availability Statement:
1. Data associated with this article are available in the Open Science Framework at .
2. The data that support the findings of this study are openly available in [repository name] at http://doi.org/[doi], reference number [reference number].
3. The data that support the findings of this study are openly available in [repository name] at [URL], reference number [reference number].
4. The data that support the findings of this study are available in [repository name] at [URL/DOI], reference number [reference number]. These data were derived from the following resources available in the public domain: [list resources and URLs] |
|